Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols
Acute Lymphoblastic Leukemia is a very aggressive malignant disorder of lymphoid cells in adults, with recurrence (30 to 60% of the cases) after the initial treatment. Until this moment, there is no gold standard therapy for the treatment of adult patients with acute relapsed/refractory lymphoblast...
Main Authors: | Flávia Tobaldini Russo, Maria Cristina Martins de Almeida Macedo, Pedro Amoedo Fernandes, Larissa Yukari Okada, Lucas Augusto Monetta da Silva, Camila Menin Simões, Jamilla Neves Cavalcante, Aline de Almeida Simões, Manuella de Souza Sampaio Almeida, Maricy Almeida Viol Ferreira Lopes, Roberto Luiz da Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2020-04-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1161 |
Similar Items
-
Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date
by: Hathaway L, et al.
Published: (2018-10-01) -
Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
by: NA Batmanova, et al.
Published: (2017-07-01) -
Oral manifestations leading to the diagnosis of acute lymphoblastic leukemia in a young girl
by: B A Silva, et al.
Published: (2012-01-01) -
DIAGNOSTIC UTILITY OF IMMUNOHISTOCHEMISTRY IN SUBTYPING ACUTE LYMPHOBLASTIC LEUKEMIA: A 2 YEARS’ EXPERIENCE
by: Nazish Farooq, et al.
Published: (2020-03-01) -
Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952
by: Marijana Vujkovic, et al.
Published: (2015-01-01)